Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2399-2403

  Akhtar, Mahmood ^a   Cheng, Yulan ^a   Magno, Romina M ^a   Ashktorab, Hassan ^b   Smoot, Duane T ^b   Meltzer, Stephen J ^a   Wilson, Keith T ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CYCLOOXYGENASE 2; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GASTROINTESTINAL CARCINOMA; GENE OVEREXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; STOMACH EPITHELIUM;

ADENOCARCINOMA; CYCLOOXYGENASE 2; DNA METHYLATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0035866790     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease
2. Pathogenesis of Helicobacter pylori infection
3. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
4. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
5. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
6. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis
7. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
8. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
9. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
10. Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase
11. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
12. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
13. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
14. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
15. Localization of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori-related gastritis and gastric ulcer tissues in humans
16. Expression of cyclooxygenase-2 in human gastric carcinoma
17. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma
18. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukotrienes Essent
19. A soluble factor from Helicobacter pylori induces expression and activity of cyclooxygenase-2
20. High output production of PGE2 by COX-2 and inhibition of apoptosis in H. Pylori-stimulated nonmalignant gastric epithelial cells
21. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro
22. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
23. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1
24. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer
25. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
26. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
27. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas
28. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors
29. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line
30. Structure of the human cyclo-oxygenase-2 gene
31. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats
32. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer
33. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells
34. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells
35. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
36. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production. Role of tumor-derived IL-10, TGF-β, and prostaglandin E2
37. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
38. Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production